Itraconazole as an alternative for ritonavir liquid formulation when combined with saquinavir

AIDS

Volumn 14, Issue 1, 2000, Pages 89-90

  Koks, Cornelis H W ^a   Van Heeswijk, Rolf P G ^a   Veldkamp, Agnes I ^a   Meenhorst, Pieter L ^a   Mulder, Jan Willem ^a   Van Der Meer, J T M ^b   Beijnen, Jos H ^a   Hoetelmans, Richard M W ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLYCOPROTEIN P; HYDROXYITRACONAZOLE; ITRACONAZOLE; RITONAVIR; SAQUINAVIR;

AREA UNDER THE CURVE; CASE REPORT; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG STABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; PRIORITY JOURNAL; SIDE EFFECT; VIRUS REPLICATION;

DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; ITRACONAZOLE; MALE; RITONAVIR; SAQUINAVIR;

EID: 0033979509     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200001070-00011     Document Type: Letter

References (9)